PTGX
Protagonist Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.40B
P/E Ratio
—
EPS
$-2.08
Beta
1.88
52W High
$107.84
52W Low
$41.28
50-Day MA
$98.72
200-Day MA
$79.97
Dividend Yield
—
Profit Margin
-282.80%
Forward P/E
23.47
PEG Ratio
0.00
About Protagonist Therapeutics Inc
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Fundamentals
| Revenue (TTM) | $46.02M |
| Gross Profit (TTM) | $46.02M |
| EBITDA | $-156.85M |
| Operating Margin | -677.00% |
| Return on Equity | -20.20% |
| Return on Assets | -14.00% |
| Revenue/Share (TTM) | $0.72 |
| Book Value | $9.82 |
| Price-to-Book | 10.28 |
| Price-to-Sales (TTM) | 139.07 |
| EV/Revenue | 125.17 |
| EV/EBITDA | 244.64 |
| Quarterly Earnings Growth (YoY) | 351.30% |
| Quarterly Revenue Growth (YoY) | -95.60% |
| Shares Outstanding | $64.31M |
| Float | $51.94M |
| % Insiders | 0.83% |
| % Institutions | 112.97% |
Historical Volatility
HV 10-Day
29.10%
HV 20-Day
40.99%
HV 30-Day
40.98%
HV 60-Day
40.64%
HV Rank
52.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($113.33 target)
3
Strong Buy8
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026